Highlights and Quick Summary
- Total non-current liabilities for the quarter ending March 31, 2023 was $354 Thousand (a -16.11% decrease compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities decreased by -36.67%
- Annual Total non-current liabilities for 2022 was $559 Thousand (a 162.44% increase from previous year)
- Annual Total non-current liabilities for 2020 was $213 Thousand (a 472.58% increase from previous year)
- Annual Total non-current liabilities for 2018 was $37.2 Thousand (a 40.91% increase from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of Benitec Biopharma Limited
Most recent Total non-current liabilitiesof BNTC including historical data for past 10 years.Interactive Chart of Total non-current liabilities of Benitec Biopharma Limited
Benitec Biopharma Limited Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.35 | – | – | – | – |
| 2022 | $0.42 | $0.49 | $0.56 | $0.64 | $0.56 |
| 2021 | – | $0.7 | $0.76 | $0.05 | – |
| 2020 | – | $0.11 | $0.16 | $0.21 | $0.21 |
| 2019 | – | – | – | $0.32 | – |
| 2018 | – | – | – | – | $0.04 |
| 2017 | – | – | – | $0.03 | $0.03 |
| 2016 | $0.02 | $0.01 | $0.01 | – | $0.01 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology